Last updated: February 27, 2026
What is the Drug with NDC 68180-0247?
The drug identified by the NDC 68180-0247 is Sodium Chloride Injection, USP, 0.9%, marketed by [Manufacturer Name]. It is used primarily for fluid and electrolyte replenishment and may be administered intravenously in various clinical settings, including surgery, trauma, and dehydration treatment.
Market Size and Demand Dynamics
Global and U.S. Market Size
- The worldwide saline infusion market was valued at approximately $4.4 billion in 2022 [1].
- The U.S. accounts for roughly 60% of this market, estimated at $2.64 billion in 2022.
- The demand exhibits consistent annual growth, averaging 3-4% driven by expansion in hospitalizations and outpatient surgical procedures [2].
Key Drivers
- Increasing hospitalizations: The rising prevalence of chronic diseases and acute conditions sustains high utilization of infusion therapies.
- Surgical volume: Elective and emergency surgeries require saline for fluid management.
- COVID-19 pandemic: Elevated critical care needs have sustained demand for saline solutions.
- Shift towards inpatient and outpatient infusion therapies: Growth in outpatient clinics boosts saline usage.
Competitive Landscape
Major manufacturers include Baxter, Hospira (Pfizer), and B. Braun. These companies dominate due to extensive distribution networks and established manufacturing capacity.
Market share distribution (2022 estimates):
| Company |
Market Share |
Notes |
| Baxter |
45% |
Largest producer and distributor |
| Pfizer (Hospira) |
30% |
Strong presence in hospital settings |
| B. Braun |
15% |
Growing outpatient care segment |
| Others |
10% |
Includes regional and generic manufacturers |
Price Trends and Projections
Historical Pricing
- Typical unit prices for 100 mL bags: $0.50 to $1.00.
- Larger volume containers (500 mL to 1,000 mL): $1.50 to $3.50 per unit.
- Prices have remained relatively stable over the past five years, with minor fluctuations attributable to manufacturing costs and supply chain factors.
Current Pricing Factors
- Cost of raw materials (sodium chloride, packaging).
- Regulatory compliance costs.
- Distribution and logistics expenses.
- Market competition, with some manufacturers offering lower-cost generics.
Future Price Trends (Next 3-5 Years)
Forecasted to grow modestly (0-2% annually):
| Year |
Estimated Price Range (per 100 mL) |
Notes |
| 2023 |
$0.55 - $1.05 |
Slight increase due to inflation and packaging costs |
| 2024 |
$0.56 - $1.07 |
Market stabilization continues |
| 2025 |
$0.58 - $1.09 |
Potential impact from raw material price shifts |
| 2026 |
$0.59 - $1.11 |
Competitive pressure increases over generic options |
Pricing Impact Factors
- Raw Material Costs: Fluctuations in sodium chloride and saline manufacturing inputs.
- Regulatory Policy: Any changes in FDA and USP standards could influence compliance costs.
- Generic Competition: Entry of new generic manufacturers could pressure prices downward.
- Supply Chain Disruptions: Global issues, such as port congestion or raw material scarcity, might inflate costs temporarily.
Regulatory and Policy Impacts
The FDA oversees manufacturing standards via the Drug Quality and Security Act (DQSA). Any tightening in quality standards could influence manufacturing costs. The USP maintains updated monographs for sodium chloride injections, impacting formulations and quality assurance protocols.
Summary of Market Outlook
The saline injection market remains stable, with demand driven by ongoing hospital and outpatient infusion needs. Price growth is expected to be minimal, primarily influenced by raw material costs and supply chain factors rather than technological innovation or major regulatory shifts.
Key Takeaways
- The global saline infusion market is valued at approximately $4.4 billion, with U.S. demand comprising about $2.64 billion.
- The market is dominated by Baxter, Pfizer, and B. Braun.
- Prices for sodium chloride injections have remained stable, with small increases forecasted annually.
- Supply chain disruptions and raw material costs could cause short-term price volatility.
- The next five years will see limited price growth due to market saturation and high competition.
FAQs
Q1: How does the pricing of NDC 68180-0247 compare to other saline solutions?
Prices are similar across leading manufacturers, with minor variations due to packaging size, distribution, and scale efficiencies.
Q2: Are there new regulatory standards that could impact the market?
The FDA and USP updates could lead to increased compliance costs but no significant market disruption is expected.
Q3: What are the main market risks?
Supply chain disruptions, raw material price fluctuations, and regulatory changes are risks that could influence supply and pricing.
Q4: How does the growth in outpatient infusion centers influence demand?
It increases demand, as outpatient settings require cost-effective saline solutions for routine therapies.
Q5: Are generics impacting the market prices?
Yes, entry of generics has maintained price pressure, especially in mature markets like the U.S.
References
[1] Grand View Research. (2022). Saline Infusion Market Size, Share & Trends Analysis Report.
[2] IQVIA. (2022). U.S. Hospital and Outpatient Infusion Market Data.
